6-1390143-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001452.2(FOXF2):c.196G>A(p.Ala66Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000234 in 1,455,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001452.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXF2 | NM_001452.2 | c.196G>A | p.Ala66Thr | missense_variant | 1/2 | ENST00000645481.2 | NP_001443.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXF2 | ENST00000645481.2 | c.196G>A | p.Ala66Thr | missense_variant | 1/2 | NM_001452.2 | ENSP00000496415 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151450Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000301 AC: 3AN: 99624Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 55902
GnomAD4 exome AF: 0.0000253 AC: 33AN: 1304066Hom.: 0 Cov.: 23 AF XY: 0.0000202 AC XY: 13AN XY: 644652
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151450Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73944
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 12, 2024 | The c.196G>A (p.A66T) alteration is located in exon 1 (coding exon 1) of the FOXF2 gene. This alteration results from a G to A substitution at nucleotide position 196, causing the alanine (A) at amino acid position 66 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
FOXF2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 28, 2024 | The FOXF2 c.196G>A variant is predicted to result in the amino acid substitution p.Ala66Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0054% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at